CHMI |
Controlled human malaria infection |
SPECT1 |
Sporozoite microneme protein essential for cell traversal |
CeLTOS |
Cell traversal protein for ookinetes and sporozoites |
PL |
Phospholipase |
HSPGs |
Heparan sulphate proteoglycans |
CSP |
Circumsporozoite protein |
TRAP |
Thrombospondin-related anonymous protein |
AMA-1 |
Apical membrane antigen 1 |
PV |
Parasitophorous vacuole |
EXP-1 |
Exported protein 1 |
LSA |
Liver stage antigen |
STARP |
Sporozoite threonine and asparagine-rich protein |
ME-TRAP |
Multi epitope TRAP |
PfSPZ |
Plasmodium falciparum sporozoite |
PfGAP3KO |
P. falciparum genetically attenuated parasite P52, p36 and sap1 deleted |
MSP |
Merozoite surface protein |
MSPDBL |
Merozoite surface protein duffy binding ligand |
EBA |
Erythrocyte binding antigen |
Rh |
Reticulocyte binding-like homologue |
RON2 |
Rhoptry neck protein 2 |
AMA1-DiCo |
Apical membrane Aantigen 1 diversity covering |
GLURP |
Glutamate-rich protein |
GMZ2 |
vaccine formulation with MSP3 and GLURP |
TEX1 |
Trophozoite exported protein |
SERA5 |
Serine repeat antigen 5 |
SPf66 |
Synthetic P. falciparum vaccine 66 |
NYVAC-Pf7 |
P. falciparum hepta-vaccine |